Concurrent Investment Advisors LLC reduced its holdings in The Clorox Company (NYSE:CLX – Free Report) by 5.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,287 shares of the company’s stock after selling 797 shares during the period. Concurrent Investment Advisors LLC’s holdings in Clorox were worth $2,483,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Insight Folios Inc lifted its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the last quarter. HCR Wealth Advisors lifted its holdings in shares of Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after acquiring an additional 68 shares during the last quarter. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after acquiring an additional 78 shares during the last quarter. Aviance Capital Partners LLC lifted its holdings in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after acquiring an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its holdings in shares of Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after acquiring an additional 88 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Stock Up 2.8 %
Shares of Clorox stock opened at $157.41 on Friday. The firm’s 50 day moving average price is $157.87 and its 200-day moving average price is $159.63. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market cap of $19.39 billion, a P/E ratio of 43.01, a PEG ratio of 2.58 and a beta of 0.42.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on CLX. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Finally, Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $158.21.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Best Aerospace Stocks Investing
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What Are Growth Stocks and Investing in Them
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Options Trading – Understanding Strike Price
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.